Ruck JM, Broderick SR. Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab. Ann Surg Oncol 2023 Oct 26. doi: 10.1245/s10434-023-14356.
PMID: 37884698